Exova Group PLC Exova sells UK & Ire Food, Water & Pharma Business (6644Y)
2016年5月19日 - 3:02PM
RNSを含む英国規制内ニュース (英語)
TIDMEXO
RNS Number : 6644Y
Exova Group PLC
19 May 2016
NEWS RELEASE
Thursday 19 May, 2016
Exova agrees to sell UK and Ireland Food, Water and
Pharmaceutical business to Eurofins Scientific
Exova Group plc, the global testing, calibration and advisory
services provider, announced today that it has entered into a
conditional sale and purchase agreement to sell its UK and Ireland
Food, Water and Pharmaceutical business to international life
sciences company, Eurofins Scientific, for a cash consideration of
around GBP18m.
The sale consists of a portfolio of ten well-established,
accredited laboratories across the UK and Ireland which provide a
wide range of chemistry and microbiological testing services.
Exova's Food, Water and Pharmaceutical business in the UK and
Ireland generated revenues of around GBP20m in 2015. It is expected
that the sale will complete early in the third quarter of 2016 on
the satisfaction of certain conditions.
Ian El-Mokadem, CEO of Exova Group plc, said: "The sale of our
Food, Water and Pharmaceutical business in the UK and Ireland
allows us to dedicate significantly more financial and management
resource to growing in sectors where we can build on our market
leading positions in technically demanding services such as Fire,
Transportation, Aerospace, Industrials and Infrastructure related
testing."
ENDS
All media enquiries, please contact:
Angela Casey
Pagoda Porter Novelli
T: +44 131 556 0770
E: angela.casey@pagodapr.com
Diana Milford, External Communications Manager
Exova Group plc
T: +44 131 335 4373
E: diana.milford@exova.com
Exova
Exova is one of the world's leading laboratory-based testing
groups, trusted by organisations to test and advise on the safety,
quality and performance of their products and operations.
Headquartered in Edinburgh, UK, Exova operates 145 laboratories and
offices in 32 countries and employs around 4,500 people throughout
Europe, the Americas, the Middle East and Asia/Asia Pacific.
Exova's capabilities help to extend asset life, bring
predictability to applications, and shorten the time to market for
customers' products, processes and materials. With over 90 years'
experience, Exova specialises in testing across a number of key
sectors from health sciences to aerospace, transportation, oil and
gas, fire and construction.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGRDVLFFQEFLBBE
(END) Dow Jones Newswires
May 19, 2016 02:02 ET (06:02 GMT)
Exova (LSE:EXO)
過去 株価チャート
から 6 2024 まで 7 2024
Exova (LSE:EXO)
過去 株価チャート
から 7 2023 まで 7 2024